1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow casimersen: new trials by email Literature Review of casimersen trials Research Report on casimersen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications. Amondys 45, Exondys 51, Vyondys 53 - Duchenne Muscular Dystrophy | Phase 2 | Completed | Kevin Flanigan | 3 | 2020-02-18 | 2023-10-26 |
Muscular Dystrophy, Duchenne (1)
Kevin Flanigan (1)
United States (1)